Hemopoietins in oncology: factoring out myelosuppression.
Griffin
J D
JD
Dana-Farber Cancer Institute, Boston.
D000818:Animals; D003115:Colony-Stimulating Factors / Q000494:pharmacology*; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000494:pharmacology*; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D009369:Neoplasms / Q000097:blood / Q000628:therapy*; D009503:Neutropenia / Q000209:etiology / Q000628:therapy
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor